1. Home
  2. ORN vs PRME Comparison

ORN vs PRME Comparison

Compare ORN & PRME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Orion Group Holdings Inc.

ORN

Orion Group Holdings Inc.

N/A

Current Price

$6.86

Market Cap

542.0M

Sector

Industrials

ML Signal

N/A

Logo Prime Medicine Inc.

PRME

Prime Medicine Inc.

N/A

Current Price

$3.57

Market Cap

526.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ORN
PRME
Founded
1994
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Military/Government/Technical
Medicinal Chemicals and Botanical Products
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
542.0M
526.0M
IPO Year
2007
2022

Fundamental Metrics

Financial Performance
Metric
ORN
PRME
Price
$6.86
$3.57
Analyst Decision
Strong Buy
Buy
Analyst Count
6
13
Target Price
★ $14.65
$7.39
AVG Volume (30 Days)
602.6K
★ 5.6M
Earning Date
10-27-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 220.00
18.18
EPS
★ 0.15
N/A
Revenue
★ $852,260,000.00
$4,632,000.00
Revenue This Year
$10.18
$150.97
Revenue Next Year
$6.44
$18.06
P/E Ratio
$46.93
★ N/A
Revenue Growth
7.01
★ 55.28
52 Week Low
$6.75
$2.67
52 Week High
$17.40
$5.91

Technical Indicators

Market Signals
Indicator
ORN
PRME
Relative Strength Index (RSI) 36.37 43.80
Support Level $6.75 $2.89
Resistance Level $9.78 $3.74
Average True Range (ATR) 0.52 0.45
MACD -0.06 -0.12
Stochastic Oscillator 7.98 5.02

Price Performance

Historical Comparison
ORN
PRME

About ORN Orion Group Holdings Inc.

Orion Group Holdings Inc is a specialty construction company serving the infrastructure, industrial, and building sectors, providing services both on and off the water in the continental United States, Alaska, Canada, and the Caribbean Basin through its marine segment and its concrete segment. Its marine segment provides construction and dredging services relating to marine transportation facility construction, marine pipeline construction, marine environmental structures, dredging of waterways, channels and ports, environmental dredging, design, and specialty services. The concrete segment generates maximum revenue and provides construction services for commercial, industrial, multi-family residential, and public projects, including the data center market.

About PRME Prime Medicine Inc.

Prime Medicine Inc is a biotechnology company focused on developing a new class of genetic medicines designed to provide durable, and potentially curative, treatment options for patients with diseases driven by defined genetic alterations, acquired cellular dysfunction, or dysregulated gene expression. Its program, PM577 for Wilson Disease, is designed to initially correct the H1069Q mutation in the ATP7B gene and is supported by preclinical data showing targeted correction and restoration of copper homeostasis in animal models. In addition, PM647 is being developed for alpha-1 antitrypsin deficiency, or AATD, another liver targeted disease with substantial unmet need.

Share on Social Networks: